Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · March 03, 2016

Bevacizumab Has Protective Effect Against Sinusoidal Obstruction After Neoadjuvant Chemotherapy for Colorectal Liver Metastasis

European Journal of Surgical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Surgical Oncology
Sinusoidal Dilation Increases the Risk of Complications in Hepatectomy for CRCLM—Protective Effect of Bevacizumab and Diabetes Mellitus, Serum Gamma-Glutamyltranspeptidase as Predictive Factor
Eur J Surg Oncol 2016 Feb 24;[EPub Ahead of Print], J Martins, H Alexandrino, R Oliveira, MA Cipriano, D Falcão, L Ferreira, R Martins, M Serôdio, M Martins, JG Tralhão, L Prado e Castro, F Castro e Sousa

Further Reading